Stockscreener 앱 받기
9.76
5.63%
0.52
시장 영업 전:
9.80
0.04
+0.41%
전일 마감가:
$9.24
열려 있는:
$9.19
하루 거래량:
346.99K
Relative Volume:
4.11
시가총액:
$80.97M
수익:
$32.03M
순이익/손실:
$-13.97M
주가수익비율:
-5.7789
EPS:
-1.6889
순현금흐름:
$-8.25M
1주 성능:
+46.33%
1개월 성능:
+58.70%
6개월 성능:
+93.27%
1년 성능:
+99.18%
1일 변동 폭
$9.08
$10.27
1주일 범위
$6.69
$10.27
52주 변동 폭
$4.16
$10.27
Electrocore Inc Stock (ECOR) Company Profile
명칭
Electrocore Inc
전화
973-290-0097
주소
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
9.76 | 76.65M | 32.03M | -13.97M | -8.25M | -1.6889 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-11-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-05-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-05-09 | 개시 | Noble Capital Markets | Outperform |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Electrocore Inc 주식(ECOR)의 최신 뉴스
Electrocore CFO and interim president Lev sells $60,003 of company stock By Investing.com - Investing.com South Africa
Electrocore CFO and interim president Lev sells $60,003 of company stock - Investing.com Nigeria
electroCore (ECOR) CFO sells 6,667 shares in open-market trade - Stock Titan
electroCore, Inc. Hits New 52-Week High of $9.18, Surpassing Previous Milestones - Markets Mojo
electroCore, Inc. Hits New 52-Week High of $9.64, Reflecting Strong Growth - Markets Mojo
electroCore (ECOR) insider sale: 3,000 shares for $19,500 reported - Stock Titan
ECOR (NASDAQ: ECOR) files Form 144 notice reporting proposed insider sales - Stock Titan
Electrocore director Thomas J. Errico buys $59,852 in stock By Investing.com - Investing.com Nigeria
electroCore Stock (ECOR) Opinions on Recent Surge and Clinical Validation - Quiver Quantitative
Electrocore director Thomas J. Errico buys $59,852 in stock - Investing.com
electroCore (ECOR) director boosts stake with 9,992-share open-market buy - Stock Titan
ElectroCore touts 30% growth outlook, VA opportunity at LD Micro Conference - MSN
ElectroCore CFO sells $19,500 in shares - Investing.com India
ElectroCore CFO sells $19,500 in shares By Investing.com - Investing.com India
electroCore (ECOR) CFO sells 3,000 shares to cover RSU taxes - Stock Titan
Electrocore Stock Price Forecast. Should You Buy ECOR? - StockInvest.us
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference - Yahoo Finance
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
ECOR: Rapid growth, unique vagus nerve tech, and new partnerships drive future expansion - TradingView
electroCore (ECOR) Stock: Down -2.49%, Support Test at $5.96 2026-05-17Dealer Delta - Newser
ElectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - marketscreener.com
electroCore (ECOR) Drops -5.29% — Key Support at $5.79 2026-05-15Imbalance Zone - Newser
electroCore (ECOR) Q1 2026 Earnings Transcript - AOL.com
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ECOR (NASDAQ) brokered sale notice: 45,000 shares valued $291,600 - Stock Titan
Quell device shows pain reduction in fibromyalgia study By Investing.com - Investing.com India
electroCore (ECOR) Reports Positive Fibromyalgia Trial Results - GuruFocus
Quell device shows pain reduction in fibromyalgia study - Investing.com
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia - The Manila Times
electroCore Announces Publication in JAMA Highlighting the - GlobeNewswire
Q2 Earnings Forecast for electroCore Issued By HC Wainwright - MarketBeat
Brokers Set Expectations for electroCore Q2 Earnings - MarketBeat
Number of shareholders of electroCore, Inc. – NASDAQ:ECOR - TradingView
Q1 Earnings Forecast for electroCore Issued By HC Wainwright - MarketBeat
ElectroCore reaffirms 2026 revenue guidance of ~30% growth while targeting deeper VA utilization - MSN
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - Sahm
electroCore to present at LD Micro Invitational XVI on May 18, 2026, highlighting bioelectronic medicine advances - Pluang
electroCore to Present at LD Micro Invitational XVI Conference on May 18, 2026 - geneonline.com
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Warby Parker (WRBY) - The Globe and Mail
Maxim Group Maintains ElectroCore(ECOR.US) With Buy Rating, Maintains Target Price $12 - Moomoo
electroCore (ECOR) Reports Strong Q1 Revenue Growth - GuruFocus
ECOR Forecasts 30% Revenue Growth for 2026 - GuruFocus
ElectroCore Q1 earnings preview - MSN
Electrocore Inc (ECOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):